| 1 |
34951582 | 5-Fluorouracil-Impregnated PLGA Coated Gold Nanoparticles for Augmented Delivery to Lung Cancer: In Vitro Investigations. | 2022 |
1 |
| 2 |
35241559 | Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer. | 2022 Mar-Apr |
2 |
| 3 |
35326562 | Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis. | 2022 Mar 10 |
1 |
| 4 |
33349222 | Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer. | 2021 |
2 |
| 5 |
33538278 | Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment. | 2021 Mar 21 |
1 |
| 6 |
33951601 | DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU). | 2021 Aug |
2 |
| 7 |
34026617 | Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. | 2021 |
1 |
| 8 |
34097885 | Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models. | 2021 Sep |
4 |
| 9 |
34589581 | Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. | 2021 Dec 17 |
7 |
| 10 |
31837576 | Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher. | 2020 Feb |
1 |
| 11 |
31840981 | Enzymes Photo-Cross-Linked to Live Cell Receptors Retain Activity and EGFR Inhibition after Both Internalization and Recycling. | 2020 Jan 15 |
1 |
| 12 |
31896739 | Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer. | 2020 Jan 2 |
4 |
| 13 |
31947551 | Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells. | 2020 Jan 14 |
4 |
| 14 |
31959339 | Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). | 2020 Feb |
1 |
| 15 |
32043796 | Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study). | 2020 Feb |
1 |
| 16 |
32742490 | Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer. | 2020 |
1 |
| 17 |
33033330 | Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles. | 2020 Oct 8 |
1 |
| 18 |
33408498 | The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. | 2020 |
2 |
| 19 |
30662270 | Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report. | 2019 |
2 |
| 20 |
30825616 | Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells. | 2019 May |
4 |
| 21 |
31189612 | Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake. | 2019 Aug |
2 |
| 22 |
31346466 | A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab. | 2019 |
2 |
| 23 |
31488078 | Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer. | 2019 Sep 5 |
1 |
| 24 |
31696188 | Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag2S quantum dots. | 2019 Dec 14 |
3 |
| 25 |
29086459 | Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic Regeneration. | 2018 Feb |
2 |
| 26 |
29480364 | Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells. | 2018 Apr |
1 |
| 27 |
29864476 | Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. | 2018 Aug 10 |
3 |
| 28 |
30056083 | Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. | 2018 Oct |
1 |
| 29 |
27878272 | miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer. | 2017 Jan |
2 |
| 30 |
26505786 | Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. | 2016 Jan 11 |
1 |
| 31 |
27091477 | Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report. | 2016 Apr 18 |
1 |
| 32 |
27268079 | Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer. | 2016 Jun 6 |
4 |
| 33 |
27340349 | Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer. | 2016 Jun 21 |
2 |
| 34 |
27602148 | Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2. | 2016 Sep |
2 |
| 35 |
27610130 | Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer. | 2016 |
1 |
| 36 |
27833077 | Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. | 2016 Dec 6 |
2 |
| 37 |
25573239 | Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies. | 2015 Mar |
2 |
| 38 |
25750344 | Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer. | 2015 Mar |
3 |
| 39 |
26088456 | First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis. | 2015 Oct |
1 |
| 40 |
26275292 | Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. | 2015 |
1 |
| 41 |
24405586 | High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil. | 2014 Mar |
5 |
| 42 |
24591842 | Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids. | 2014 |
1 |
| 43 |
22052826 | Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. | 2013 Mar |
1 |
| 44 |
23708506 | Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. | 2013 Aug |
1 |
| 45 |
23755922 | Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy. | 2013 Aug 1 |
2 |
| 46 |
23800895 | Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy. | 2013 Dec |
5 |
| 47 |
23822592 | Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody. | 2013 Oct |
4 |
| 48 |
24221219 | [Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck : highlights of the ASCO Meeting 2013]. | 2013 Nov |
1 |
| 49 |
24351824 | Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells. | 2013 Dec 16 |
2 |
| 50 |
21947696 | Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. | 2012 Mar |
1 |